Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-05-25

Clinical Trial Update: Study Evaluating the Pharmacokinetics of Keppra Extended Release (XR) in Children and Adults With Epilepsy [Phase 2]

View source ↗

Summary

Phase 2 pharmacokinetics study of Keppra Extended Release (XR) in children and adults with epilepsy has completed and results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Keppra Extended Release (XR) (levetiracetam)

Snippet

Sponsor: UCB BIOSCIENCES, Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2011-05-25